November 5 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its sales revenue rose by an annual 6% in the January-October period of 2019, due to higher sales on foreign markets.
Sopharma's domestic sales fell 4% year-on-year in the first ten months of 2019, while sales abroad grew 13%, the company said in a bourse filing.
In October alone, the company's sales jumped 40%. Exports were 48% higher on the year, while domestic sales grew 30%.
The company did not disclose information about the volume of its sales or amount of sales revenue.